Why Lower Doses of Cancer Drugs Remain Elusive

Why Lower Doses of Cancer Drugs Remain Elusive



Why Lower Doses of Cancer Drugs Remain Elusive
Hi, It’s Bob in New York and Swati in New Delhi. We talked to a man who illustrates how a radical new dosing regimen could bring powerful immune therapies to cancer patients in developing countries. More on him in a moment, but first …


www.bloomberg.com
#Doses #Cancer #Drugs #Remain #Elusive

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *